Roche’s investigational treatment for asthma met its primary endpoint in a phase II study
4 August 2011 | By Roche
Lebrikizumab has potential to be the first personalized treatment for asthma...
List view / Grid view
4 August 2011 | By Roche
Lebrikizumab has potential to be the first personalized treatment for asthma...
3 August 2011 | By kdm communications limited
With increased affordability for CompoZr® ZFNs and the expansion of Knockout ZFNs to include every gene in mice and rats...
3 August 2011 | By Roche
The European Commission has approved the use of RoACTEMRA (tocilizumab)...
Thermo Fisher Scientific Inc., the world leader in serving science, today announced its updated Build-Your-Own FT-IR website.
3 August 2011 | By Pfizer
NCCN has received a $2 million educational grant from Pfizer to help support the first CME program...
3 August 2011 | By Merck
Merck and Serum Institute of India Limited announced an agreement to work together...
3 August 2011 | By Cancer Research UK
CANCER RESEARCH UK scientists have developed a new imaging technique...
2 August 2011 | By The Scott Partnership
Dr. James Sawyer, selected as one of the 100 most inspirational & influential people...
2 August 2011 | By AstraZeneca
AstraZeneca announced that AXANUM has received positive agreement for approval...
1 August 2011 | By Merck KGaA
Merck Millipore has completed the acquisition of the microbiology business of Biotest AG...
1 August 2011 | By Pfizer
Pfizer Inc. has completed the sale of its Capsugel business to an affiliate of Kohlberg Kravis Roberts & Co. L.P...
29 July 2011 | By Eli Lilly
Collaboration to promote and distribute Lilly's Huminsulin range of products...
29 July 2011 | By Bristol-Myers Squibb
ORENCIA® (abatacept) treatment for adults with moderate to severe rheumatoid arthritis (RA)...
29 July 2011 | By Pfizer
The U.S. FDA issued a 90-day extension to the action date for the Company’s sBLA for use of Prevnar 13®...
28 July 2011 | By Sanofi
Sanofi has appointed Dr. David-Alexandre Gros as Chief Strategy Officer, effective September 1, 2011...